サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1785968

ケモインフォマティクスの世界市場

Chemoinformatics

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
ケモインフォマティクスの世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ケモインフォマティクスの世界市場は2030年までに90億米ドルに達する見込み

2024年に38億米ドルと推定されるケモインフォマティクスの世界市場は、2024年から2030年にかけてCAGR 15.3％で成長し、2030年には90億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである化学分析アプリケーションは、CAGR 17.5%を記録し、分析期間終了までに39億米ドルに達すると予測されます。創薬アプリケーション分野の成長率は、分析期間中CAGR 15.0％と推定されます。

米国市場は10億米ドルと推定、中国はCAGR20.7%で成長予測

米国のケモインフォマティクス市場は、2024年に10億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 20.7%で推移し、2030年までに20億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.1%と13.8%と予測されています。欧州では、ドイツがCAGR約12.2%で成長すると予測されています。

世界のケモインフォマティクス市場- 主要動向と促進要因のまとめ

分子データは創薬の未来を形作れるか？

ケモインフォマティクスは、製薬研究を加速させる化学データと計算ツールの橋渡し役として機能し、現代の創薬において極めて重要なイネーブラーとして急速に台頭しています。分子データセットの複雑化、化合物ライブラリーの増大、新薬の市場投入までの時間を短縮する必要性により、ケモインフォマティクスは医薬品の研究開発において不可欠なツールとなっています。このテクノロジーは、構造活性相関モデリング、バーチャルスクリーニング、定量的構造活性相関（QSAR）解析、分子ドッキングシミュレーションなどの重要なプロセスをサポートし、パイプラインの初期段階で実行可能な新薬候補を特定する上で重要な役割を果たします。ケモインフォマティクスとハイスループットスクリーニングやラボの自動化との統合は、ヒットからリードへの最適化戦略を大幅に改善します。さらに、プレシジョン・メディシンの境界が拡大し続ける中、ケモインフォマティクスの特定の分子ターゲットに合わせた化合物設計の能力は、これまで以上に重要性を増しています。業界では、従来のウェットラボでの試行錯誤的アプローチから、研究開発コストの削減と予測精度の向上を実現するインシリコ・モデリングへの移行が顕著になっています。製薬、農薬、材料科学の各分野で、化合物の特性予測、リード化合物の最適化、毒性解析、ターゲット予測のために、ケモインフォマティクスプラットフォームを利用する企業が増えています。

人工知能はどのようにケモインフォマティクスの展望を変えるのか？

人工知能（AI）と機械学習（ML）のケモインフォマティクスとの融合は、分子データの解釈、分析、活用方法を根本的に再定義しています。AIを搭載したケモインフォマティクスプラットフォームは、過去の化合物データから学習し、de novo分子設計、ADMETプロファイリング、多目的最適化を支援する予測モデルを生成することができます。これらの機能は、臨床候補化合物の減少率を低減し、化合物の有効性を高めることを目指す医薬品開発者にとって不可欠なツールになりつつあります。自然言語処理（NLP）は化学文献や特許のマイニングにも利用され、化合物開発により豊富で実用的なデータセットを提供しています。さらに、ディープラーニングのフレームワークは、これまでにない精度で新規化合物の足場やバイオアイソステリック置換を同定するのに役立っています。AIで強化されたケモインフォマティクスツールは、化学合成計画、反応予測、逆合成分析にも採用され、アイデア出しから合成までのエンドツーエンドの化合物ライフサイクル管理を可能にしています。クラウドベースのインフラストラクチャの採用が進むにつれ、特に中小規模のバイオテクノロジー企業にとって、AIを統合したケモインフォマティクスソリューションのスケーラビリティとアクセシビリティがさらに高まっています。医薬品イノベーション競争における競争が激化する中、企業はケモインフォマティクス、バイオインフォマティクス、AIを組み合わせたハイブリッドデータプラットフォームに注目し、これまで人力では分析できなかった隠れたパターンや相関関係を明らかにしようとしています。

規制上の要求とデータの標準化がデジタルケミストリーへのシフトを後押し？

医薬品の安全性、データの透明性、品質コンプライアンスに対する規制当局の監視が強化される中、ケモインフォマティクスは単なる調査ツールではなく、規制当局のインテリジェンスと意思決定の重要な要素として見なされるようになってきています。組織は、化合物開発パイプラインの再現性、一貫性、データのトレーサビリティを実証する必要があります。SMILES（Simplified Molecular Input Line Entry System）、InChI、SDファイルなどの標準化されたデータフォーマットの採用は、クロスプラットフォームでの相互運用性と規制当局への申請を容易にします。毒性学的モデリングや予測安全性評価におけるケモインフォマティクスツールの使用は、REACH、OECDガイドライン、ICH安全性評価などの規制の枠組みにも適合しています。化粧品、栄養補助食品、農薬など、動物実験がますます制限されている分野では、ケモインフォマティクスを使用することで、in silicoによる毒性予測や代替試験戦略が可能になります。また、共同創薬やオープンイノベーションのエコシステムの台頭により、研究パートナーやCRO間での安全でリアルタイムなデータ共有をサポートする、一元化されたクラウド対応のケモインフォマティクスプラットフォームへの需要が高まっています。さらに、ケモインフォマティクスと電子実験ノート（ELN）、実験室情報管理システム（LIMS）、データ可視化ツールとの統合により、化合物設計からアッセイ分析までの完全なトレーサビリティが確保され、コンプライアンス対応とプロセスの完全性が強化されます。

ケモインフォマティクスソリューションの普及を促進する要因とは？

ケモインフォマティクス市場の成長は、技術の進歩、業界慣行の変化、エンドユーザーの期待の変化と密接に結びついたいくつかの要因によって牽引されています。より迅速でコスト効率の高い創薬プロセスへの要求の高まりにより、製薬企業やバイオテクノロジー企業はデータ主導型の研究開発インフラに多額の投資を行うようになり、ケモインフォマティクスプラットフォームはその重要な柱となっています。化合物スクリーニングライブラリや分子標的ランドスケープの複雑化に伴い、化合物の選択、設計、最適化を効率化できる強固な計算ツールが必要とされています。科学研究におけるAIと機械学習の普及は、ケモインフォマティクスプラットフォームの予測力と自動化機能を強化し、次世代の研究開発ラボに不可欠なものとなっています。さらに、化学研究における予測毒性学、グリーンケミストリー、持続可能性の重視の高まりは、環境影響モデリングや安全性プロファイリングにおけるケモインフォマティクスツールの新たな使用事例を生み出しています。分散型、共同研究環境へのシフトは、クラウド対応、相互運用可能なケモインフォマティクスソリューションへの依存度を高めています。さらに、医薬品開発パイプラインにおけるデータの標準化と規制遵守の重要性が高まっているため、企業はエンドツーエンドの化合物データ管理のために統合されたケモインフォマティクスシステムを採用せざるを得なくなっています。研究開発チームは、深い洞察力と運用の俊敏性を兼ね備えたツールを求めており、ケモインフォマティクスプラットフォームは、急速に最新の化学・製薬研究エコシステムの基盤になりつつあります。

セグメント

アプリケーション（化学分析アプリケーション、創薬アプリケーション、医薬品バリデーションアプリケーション、その他のアプリケーション）

調査対象企業の例

  • Agilent Technologies Inc.
  • Atomwise
  • Bio-Rad Laboratories Inc.
  • BioSolveIT GmbH
  • ChemAxon Ltd
  • Chemical Computing Group ULC
  • Collaborative Drug Discovery Inc.
  • Dassault Systemes（BIOVIA）
  • Deep Genomics
  • Discngine
  • Eurofins CEREP SA（Eurofins Panlabs Inc.）
  • Harmonic Discovery
  • Ignota Labs
  • Insilico Medicine
  • Jubilant Biosys Ltd
  • Molecular Discovery Ltd
  • OpenEye Scientific Software Inc.
  • Quantori
  • Schrodinger, Inc.
  • Scilligence

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29923

Global Chemoinformatics Market to Reach US$9.0 Billion by 2030

The global market for Chemoinformatics estimated at US$3.8 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Chemical Analysis Application, one of the segments analyzed in the report, is expected to record a 17.5% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Drug Discovery Application segment is estimated at 15.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 20.7% CAGR

The Chemoinformatics market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 20.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 13.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.

Global Chemoinformatics Market - Key Trends & Drivers Summarized

Can Molecular Data Shape the Future of Drug Discovery?

Chemoinformatics has rapidly emerged as a pivotal enabler in modern drug discovery, acting as a bridge between chemical data and computational tools to accelerate pharmaceutical research. The increasing complexity of molecular datasets, growing volumes of compound libraries, and the need to reduce time-to-market for new drugs have made chemoinformatics an indispensable tool in pharmaceutical R&D. This technology supports key processes such as structure-activity relationship modeling, virtual screening, quantitative structure-activity relationship (QSAR) analysis, and molecular docking simulations, all of which play a vital role in identifying viable drug candidates early in the pipeline. The integration of chemoinformatics with high-throughput screening and laboratory automation is significantly improving hit-to-lead optimization strategies. Furthermore, as the boundaries of precision medicine continue to expand, the ability of chemoinformatics to tailor compound design for specific molecular targets is becoming more relevant than ever. The industry is witnessing a marked shift from traditional wet-lab trial-and-error approaches to in silico modeling, which reduces R&D costs and enhances prediction accuracy. Organizations across pharmaceuticals, agrochemicals, and material sciences are increasingly relying on chemoinformatics platforms for compound property prediction, lead optimization, toxicity analysis, and target prediction, thereby transforming the overall research workflow and decision-making process.

How Is Artificial Intelligence Transforming the Chemoinformatics Landscape?

The fusion of artificial intelligence (AI) and machine learning (ML) with chemoinformatics is fundamentally redefining how molecular data is interpreted, analyzed, and utilized. AI-powered chemoinformatics platforms are capable of learning from historical compound data and generating predictive models that aid in de novo molecular design, ADMET profiling, and multi-objective optimization. These capabilities are becoming essential tools for drug developers aiming to reduce the attrition rate of clinical candidates and enhance compound efficacy. Natural language processing (NLP) is also being used to mine chemical literature and patents, providing richer, more actionable datasets for compound development. In addition, deep learning frameworks are helping identify novel compound scaffolds and bioisosteric replacements with unprecedented accuracy. AI-enhanced chemoinformatics tools are also being adopted in chemical synthesis planning, reaction prediction, and retrosynthesis analysis-enabling end-to-end compound lifecycle management from ideation to synthesis. The growing adoption of cloud-based infrastructure has further amplified the scalability and accessibility of AI-integrated chemoinformatics solutions, especially for small and mid-sized biotech firms. As competition in the pharmaceutical innovation race intensifies, organizations are turning toward hybrid data platforms that combine chemoinformatics, bioinformatics, and AI to uncover hidden patterns and correlations that were previously beyond human analysis.

Are Regulatory Demands and Data Standardization Fueling the Shift to Digital Chemistry?

With growing regulatory scrutiny on drug safety, data transparency, and quality compliance, chemoinformatics is increasingly viewed not just as a research tool but as a critical component of regulatory intelligence and decision-making. Organizations must now demonstrate reproducibility, consistency, and data traceability across compound development pipelines-capabilities that are inherently built into modern chemoinformatics platforms. The adoption of standardized data formats such as SMILES (Simplified Molecular Input Line Entry System), InChI, and SD files facilitates cross-platform interoperability and regulatory submissions. The use of chemoinformatics tools in toxicological modeling and predictive safety assessments also aligns with regulatory frameworks such as REACH, OECD guidelines, and ICH safety evaluations. In sectors such as cosmetics, nutraceuticals, and agrochemicals, where animal testing is increasingly restricted, chemoinformatics enables in silico toxicity prediction and alternative testing strategies. The rise in collaborative drug discovery and open innovation ecosystems is also driving demand for centralized, cloud-compatible chemoinformatics platforms that support secure, real-time data sharing across research partners and CROs. Moreover, the integration of chemoinformatics with electronic lab notebooks (ELNs), laboratory information management systems (LIMS), and data visualization tools ensures full traceability from compound design to assay analysis, thereby reinforcing compliance-readiness and process integrity.

What Forces Are Driving the Rising Adoption of Chemoinformatics Solutions?

The growth in the chemoinformatics market is driven by several factors closely tied to technological advancement, shifting industry practices, and changing end-user expectations. The increasing demand for faster and more cost-efficient drug discovery processes is leading pharmaceutical and biotech companies to invest heavily in data-driven R&D infrastructure, where chemoinformatics platforms serve as a critical pillar. The rising complexity of compound screening libraries and molecular target landscapes necessitates robust computational tools that can streamline compound selection, design, and optimization. The proliferation of AI and machine learning in scientific research is enhancing the predictive power and automation capabilities of chemoinformatics platforms, making them indispensable in next-generation R&D labs. Additionally, the growing emphasis on predictive toxicology, green chemistry, and sustainability in chemical research is creating new use cases for chemoinformatics tools in environmental impact modeling and safety profiling. The shift toward decentralized and collaborative research environments is increasing reliance on cloud-enabled, interoperable chemoinformatics solutions. Furthermore, the rising importance of data standardization and regulatory compliance across drug development pipelines is compelling organizations to adopt integrated chemoinformatics systems for end-to-end compound data management. As R&D teams seek tools that offer both depth of insight and operational agility, chemoinformatics platforms are rapidly becoming the foundation of modern chemical and pharmaceutical research ecosystems.

SCOPE OF STUDY:

The report analyzes the Chemoinformatics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Chemical Analysis Application, Drug Discovery Application, Drug Validation Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies Inc.
  • Atomwise
  • Bio-Rad Laboratories Inc.
  • BioSolveIT GmbH
  • ChemAxon Ltd
  • Chemical Computing Group ULC
  • Collaborative Drug Discovery Inc.
  • Dassault Systemes (BIOVIA)
  • Deep Genomics
  • Discngine
  • Eurofins CEREP SA (Eurofins Panlabs Inc.)
  • Harmonic Discovery
  • Ignota Labs
  • Insilico Medicine
  • Jubilant Biosys Ltd
  • Molecular Discovery Ltd
  • OpenEye Scientific Software Inc.
  • Quantori
  • Schrodinger, Inc.
  • Scilligence

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Chemoinformatics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Dependence on In Silico Drug Discovery Throws the Spotlight on Chemoinformatics Platforms
    • Integration of AI and Machine Learning Propels Growth in Predictive Molecular Modeling Applications
    • Expansion of Complex Compound Libraries Expands Addressable Market Opportunity for Advanced Chemoinformatics Tools
    • Shift Toward Data-Driven R&D Strengthens the Business Case for Chemoinformatics in Pharmaceutical Pipelines
    • Rising Adoption of Cloud-Based Platforms Drives Digital Transformation in Molecular Informatics Workflows
    • Emergence of Hybrid Chemoinformatics-Bioinformatics Systems Spurs Demand for Integrated Data Analytics Ecosystems
    • Increasing Focus on Personalized Medicine Accelerates Demand for Target-Specific Compound Design Tools
    • Regulatory Push for Predictive Toxicology and Safety Modeling Generates Demand for Chemoinformatics-Based Compliance Solutions
    • Automation in High-Throughput Screening Workflows Drives Adoption of Chemoinformatics in Early-Stage Drug Development
    • Growing Investment in Novel Therapeutics and Biologics Fuels Demand for Advanced Molecular Visualization and QSAR Tools
    • Widening Application in Agrochemicals and Materials Science Expands Cross-Industry Market Potential
    • Collaborative Drug Discovery Initiatives Strengthen Market Need for Interoperable and Scalable Chemoinformatics Solutions
    • Data Standardization and Format Harmonization Issues Highlight the Need for Unified Chemoinformatics Frameworks
    • Rising Use of Natural Language Processing (NLP) in Chemical Literature Mining Spurs Innovation in Data Curation Capabilities
    • Increased Emphasis on Open-Source Platforms and Academic-Industry Synergies Sustains Growth in Accessible Chemoinformatics Toolsets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Chemoinformatics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Chemoinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Chemoinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Chemoinformatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chemical Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chemical Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Chemical Analysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Validation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Validation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Drug Validation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Chemoinformatics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Chemoinformatics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Chemoinformatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Chemoinformatics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Chemoinformatics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Chemoinformatics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Chemoinformatics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Chemoinformatics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Chemoinformatics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Chemoinformatics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Chemoinformatics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Chemoinformatics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Chemoinformatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Chemoinformatics by Application - Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Chemoinformatics by Application - Percentage Breakdown of Value Sales for Chemical Analysis Application, Drug Discovery Application, Drug Validation Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION